{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:57:58Z","timestamp":1784667478932,"version":"3.55.0"},"reference-count":35,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>The main goal of our study is the impact evaluation of complex urate-lowering therapy with the synbiotic addition on fecal microbiota and cytokine profile in patients with primary gout. During our study, 130 men (mean age 55.5 \u00b1 9.4 years) with gout (duration 7.7 \u00b1 7.1 years) were examined. All patients were divided into two treatment groups. The main group (n = 68) was taking allopurinol at 300 mg per day dose and additionally a synbiotic. The comparison group (n = 62) received allopurinol monotherapy without synbiotic intake. The therapy duration was 3 months. Evaluation of therapy efficiency was marked by blood uric acid changes, cytokine levels, CRP and fecal microbiota condition. After treatment, stabilization of the gut microbiota parameters was observed, which was leading to normalization uricemia levels (40.3% vs. 21%, p &lt;0.01) in the main group patients. Addition of synbiotic to allopurinol leads to a blood uric acid lowering (18.7% vs. 13.3%, p &lt;0.01), CRP reduction (75% vs. 26.3%, p &lt;0.01) as well as decrease of cytokines level: IL-1\u03b2, IL-6, IL-8, IL-10 and TNF\u03b1 (all p &lt;0.001). After a 3-month gout treatment, a group of patients who received complex therapy with synbiotic inclusion showed signs of disease remission characterized by inflammation activity reducing, fecal microbiota condition normalization and a more pronounced decrease in laboratory markers comparing to control group.<\/jats:p>","DOI":"10.25122\/jml-2020-0065","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:31:45Z","timestamp":1668760305000},"page":"490-498","source":"Crossref","is-referenced-by-count":22,"title":["Impact of the Synbiotics and Urate-Lowering Therapy on Gut Microbiota and Cytokine Profile in Patients with Chronic Gouty Arthritis"],"prefix":"10.25122","volume":"13","author":[{"given":"Vitalii","family":"Evgenovich Kondratiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Internal Medicine No 2., Bogomolets National Medical University","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Mykhailivna Tarasenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Rheumatology Department, Kyiv City Hospital No 3., Kyiv, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Oksana Tarasenko Rheumatologist, Kyiv City Hospital No. 3, Kyiv, Ukraine 02125, Kyiv, 26 P. Zaporozhtsa Str.Phone: +380962603725 E-mail: kondratiuk_v@ukr.net","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Myroslavivna Karmazina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Internal Medicine No 2., Bogomolets National Medical University","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyn","family":"Valentinovich Taranchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Internal Medicine No.1, Bogomolets National Medical University","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Jansen TL, Janssen M. The American College of Physicians and the 2017 guideline for the management of acute and recurrent gout: treat to avoiding symptoms versus treat to target. Clin Rheumatol .2017; DOI: 10.1007\/s10067-017-3840-1.","DOI":"10.1007\/s10067-017-3840-1"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Edwards NL, Sundy JS, Forsythe A, Blume S, Pan F, Becker MA. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. Journal of medical economics. 2011; doi: 10.3111\/13696998.2010.540874.","DOI":"10.3111\/13696998.2010.540874"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Kim KY, Schumacher RH, Hunsche E, Wertheimer AI, Kong SX. A literature review of the epidemiology and treatment of acute gout. Clin Ther. 2003; DOI:10.1016\/s0149-2918(03)80158-3.","DOI":"10.1016\/S0149-2918(03)80158-3"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Qaseem A, Harris RP, Forciea MA. Management of Acute and Recurrent Gout: A clinical Practice Guideline from the American College of Physicians. Ann Intern Med. 2017; doi:10.7326\/M16-0570.","DOI":"10.7326\/M16-2367"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Robinson PC, Horsburgh S. Gout:joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas. 2014; doi: 10.1016\/j.maturitas.2014.05.001.","DOI":"10.1016\/j.maturitas.2014.05.001"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Hyndman D, Liu S, Miner JN. Urate handling in the human body. Curr.Rheumatol Rep. \u2013 2016; doi: 10.1007\/s11926-016-0587-7.","DOI":"10.1007\/s11926-016-0587-7"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W, Brown J, Stillman DJ, O\u2019Connell RM, Tebo AE, Round JL. A member of the gut mycrobiota modulates host purine metabolism is exacerbating colitis in mic. Science Translational Medicine. 2017; DOI:10.1126\/scitranslmed.aaf9044.","DOI":"10.1126\/scitranslmed.aaf9044"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. International journal of Cardiology. 2016; doi: 10.1016\/j.ijcard.2015.08.109.","DOI":"10.1016\/j.ijcard.2015.08.109"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L, Koh E, Danliang H, Xu J, Lee YK, Zhang H. Intestinal Microbiota Distinguish Gout Patients from Healthy Humans. Sci Rep. 2016; doi:10.1038\/srep20602.","DOI":"10.1038\/srep20602"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Karkman A, Lehtim\u00e4ki J, Ruokolainen L. The ecology of human microbiota: dynamics and diversity in health and disease. Ann. N. Y. Acad. Sci. 2017; doi: 10.1111\/nyas.13326.","DOI":"10.1111\/nyas.13326"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Bai YH, Jiang YF, Jiang YS. Lactobacillus bulgaricus mutants decompose uremic toxins. Renal Failure -2014; doi: 10.3109\/0886022X.2014.890111.","DOI":"10.3109\/0886022X.2014.890111"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Bhathena J, Martoni C, Kulamarva A, Tomaro-Duchesneau C, Malhotra M, Paul A, Urbanska AM, Prakash S. Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters. PLoS ONE. 2013; doi: 10.1371\/journal.pone.0058394.","DOI":"10.1371\/journal.pone.0058394"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Chen RJ, Chen MH, Chen YL, Hsiao CM, Chen HM, Chen SJ, Wu MD, Yech YJ, Yuan GF, Wang YJ. Evaluating the urate-lowering effects of different microbial fermented extracts in hyperuricemic models accompanied with a safety study. J Food Drug Anal. 2016; doi: 10.1016\/j.jfda.2016.07.003.","DOI":"10.1016\/j.jfda.2016.07.003"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Cleophas MC, Cri\u015fan TO, Joosten LA. Factors modulating the inflammatory response in acute gouty arthritis. Curr Opin Rheumatol. 2017; doi: 10.1097\/BOR.0000000000000366.","DOI":"10.1097\/BOR.0000000000000366"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Reginato AM, Mount DB, Yang I, Choi HK. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol. 2012; doi: 10.1038\/nrrheum.2012.144.","DOI":"10.1038\/nrrheum.2012.144"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Slavin J. Fiber and Prebiotics: Mechanisms and Health Benefits. Nutrients. 2013; DOI: 10.3390\/nu5041417.","DOI":"10.3390\/nu5041417"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Vieira AT, Galv\u00e3o I, Amaral FA, Teixeira MM, Nicoli JR, Martins FS. Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine model of experimental gout. Beneficial Microbes. 2015; doi: 10.3920\/BM2015.0015.","DOI":"10.3920\/BM2015.0015"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Li M, Yang D, Mei L, Yuan L, Xie A, Yuan J. Screening and Characterization of Purine NucleosideDegrading Lactic Acid Bacteria Isolated from Chinese Sauerkraut and Evaluation of the Serum Uric Acid Lowering Effect in Hyperuricemic Rats. PLoS One. 2014; doi: 10.1371\/journal.pone.0105577.","DOI":"10.1371\/journal.pone.0105577"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. Hypouricaemic effects of yogurt containing Lactobacillus gasseri PA-3in patients with hyperuricaemia and\/or gout: A randomized, double- blind, placebo-controlled study. Modern Rheum. J. 2019; doi: 10.1080\/14397595.2018.1442183.","DOI":"10.1080\/14397595.2018.1442183"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Yang D, Yu X, Wu Y, Chen X, Wei H, Shah NP, Xu F. Enhancing flora balance in the gastrointestinal tract of mice by lactic acid bacteria from Chinese sourdough and enzyme activities metabolism of protein, fat, and carbohydrate by the flora. Journal of Dairy science. 2016; doi: 10.3168\/jds.2016-11467.","DOI":"10.3168\/jds.2016-11467"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Coussa R, Martoni C, Bhathena J, Urbanska AM, Prakash S. Oral microencapsulated live Saccharomyces cerevisiaecells for use in renal failure uremia: preparation and in vivoanalysis. J. Biomedicine and Biotechnology. 2010; doi: 10.1155\/2010\/620827.","DOI":"10.1155\/2010\/620827"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Schett G, Schauer C, Hoffmann M, Herrmann M. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout. RMD Open.2015; doi: 10.1136\/rmdopen-2015-000046.","DOI":"10.1136\/rmdopen-2015-000046"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Xu X, Li C, Zhou P, Jiang T. Uric acid transporters hiding in the intestine. Pharmaceutical biology. 2016; doi: 10.1080\/13880209.2016.1195847.","DOI":"10.1080\/13880209.2016.1195847"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Pereira FC, Berry D. Microbial nutrient niches in the gut. Environ Microbiol. 2017; doi: 10.1111\/1462-2920.13659.","DOI":"10.1111\/1462-2920.13659"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Masanetz S, Prei\u00dfinger W, Meyer HH, Pfaffl MW. Effects of the prebiotics inulin and lactulose on intestinalimmunology and hematology of preruminant calves. Animal.2011; doi:10.1017\/S1751731110002521.","DOI":"10.1017\/S1751731110002521"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Schley PD & Field CJ. The immune-enhancing effects of dietary fibers and prebiotics.Br. J. Nutr. 2002; DOI: 10.1079\/BJNBJN\/ 2002541.","DOI":"10.1079\/BJN\/2002541"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Watzl B, Girrbach S, Roller M. Inulin, oligofructose and immunomodulation. British Journal of Nutrition. 2015; doi: 10.1079\/bjn20041357.","DOI":"10.1079\/BJN20041357"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Lin Z, Zhang B, Liu X, Jin R, Zhu W. Effects of Chicory Inulin on Serum Metabolites of Uric Acid, Lipids, Glucose, and Abdominal Fat Deposition in Quails Induced by Purine-Rich Diets. Journal of medical Food. 2017; doi: 10.1089\/jmf.2013.2991.","DOI":"10.1089\/jmf.2013.2991"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Venuto C, Butler M, Ashley ED, Brown J. Alternative therapies for Clostridium difficult infections. Pharmacotherapy. 2010; doi: 10.1592\/phco.30.12.1266.","DOI":"10.1592\/phco.30.12.1266"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Sheridan PO, Martin JC, Lawley TD, Browne HP, Harris HMB, Bernalier-Donadille A, Duncan SH, O\u2019Toole PW, P Scott K, J Flint H. Polysaccharide utilization loci and nutritional specialization in a dominant group of butyrate-producing human colonic Firmicutes.Microb. Genom. 2016; doi:10.1099\/mgen.0.000043.","DOI":"10.1099\/mgen.0.000043"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Gonzalez EB. An update on the pathology and clinical management of gouty arthritis. Clin Rheumatol. 2012; doi: 10.1007\/s10067-011-1877-0.","DOI":"10.1007\/s10067-011-1877-0"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003; DOI: 10.1038\/nature01991.","DOI":"10.1038\/nature01991"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Amaral FA, Bastos LF, Oliveira TH, Dias AC, Oliveira VL, Tavares LD, Costa VV, Galv\u00e3o I, Soriani FM, Szymkowski DE, Ryffel B, Souza DG, Teixeira MM. Transmembrane TNF-\u03b1 is sufficient for andhypernociception articular inflammation in a mouse model of gout. Eur. J. Immunol. 2016; doi: 10.1002\/eji.201545798.","DOI":"10.1002\/eji.201545798"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Liu-Bryan R, Terkeltaub R. Tophus Biology and Pathogenesis of MonosodiumUrate Crystal-Induced Inflammation. Gout and OtherCrystal Deposition Arthropathies. 2011; DOI: 10.1016\/B978-1-4377-2864-4.10005-3.","DOI":"10.1016\/B978-1-4377-2864-4.10005-3"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Cavalcanti NG, Marques CD, Lins E Lins TU, Pereira MC, R\u00eago MJ, Duarte AL, Pitta Ida R, Pitta MG. Cytokine Profile in Gout: Inflammation Driven by IL-6 and IL-18? Immunol. Inves. 2016; doi: 10.3109\/08820139.2016.1153651.","DOI":"10.3109\/08820139.2016.1153651"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-13-490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:32:20Z","timestamp":1668760340000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-13-490.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["JMedLife-13-490"],"URL":"https:\/\/doi.org\/10.25122\/jml-2020-0065","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}